MARC Record from harvard_bibliographic_metadata

LEADER: 03315cam a2200481 a 4500
001 013518887-3
005 20130308190215.0
008 120910s2012 gw a b 100 0 eng
010 $a 2012949069
016 7 $a101599050$2DNLM
016 7 $a1023292114$2DE-101
020 $a9783642316289 (alk. paper)
020 $a364231628X (alk. paper)
020 $a9783642316296 (ebook)
020 $a3642316298 (ebook)
035 0 $aocn819379378
040 $aNLM$beng$cNLM$dOHX$dDLC$dYDXCP$dPAU$dOCLCO$dMMU$dCDX$dOCLCO
042 $alccopycat$apcc
050 00 $aRC280.D5$bE275 2012
050 14 $aRC261$b.R35 v.196 2012
060 00 $aW1$bRE106P v.196 2012
060 10 $aWI 149
072 7 $aRC$2lcco
082 04 $a616.9943
245 00 $aEarly gastrointestinal cancers /$cFlorian Otto, Manfred P. Lutz, editors.
260 $aHeidelberg :$bSpringer,$cc2012.
300 $axii, 318 p. :$bill. :$c24 cm.
490 1 $aRecent results in cancer research,$x0080-0015 ;$v196
500 $a"Contains the majority of the invited expert contributions from the First St. Gallen EORTC Gastrointestinal Cancer Conference, held on 22-24 March 2012 in St. Gallen, Switzerland."--p. [4] of cover.
504 $aIncludes bibliographical references.
505 0 $aClinically relevant study end points in rectal cancer -- Neoadjuvant treatment in rectal cancer : do we always need radiotherapy or can we risk assess locally advanced rectal cancer better? -- Treatment dilemmas in patients with synchronous colorectal liver metastases -- Pancreatic surgery : beyond the traditional limits -- Adjuvant therapy for pancreatic cancer -- Radiotherapy of the pancreas : state of the art in 2012 -- Adenocarcinoma of the GEJ : gastric or oesophageal cancer? -- Why is there a change in patterns of GE cancer? -- Endoscopic treatment for esophageal squamous cell carcinoma -- Open or minimally invasive resection for oesophageal cancer? -- Choosing the best treatment for esophageal cancer -- Multimodal therapy of GEJ cancer : when is the definitive radiochemotherapy the treatment of choice? -- Radiotherapy of gastroesophageal junction cancer -- Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography -- Optimal surgery for gastric cancer : is more always better? -- Can adjuvant chemoratiotherapy replace extended lymph node dissection in gastric cancer? -- Predicting the response to chemotherapy in gastric adenocarcinoma : who benefits from neoadjuvant chemotherapy? -- Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients -- Adjuvant chemotherapy : an option for Asian patients only? -- Selecting the best treatment for an individual patient.
650 22 $aEarly Medical Intervention.
650 22 $aEarly Detection of Cancer.
650 12 $aGastrointestinal Neoplasms$xtherapy.
650 12 $aGastrointestinal Neoplasms$xdiagnosis.
655 2 $aCongresses
650 0 $aGastrointestinal system$xCancer.
700 1 $aOtto, Florian.
700 1 $aLutz, Manfred P.
711 2 $aSt. Gallen EORTC Gastrointestinal Cancer Conference$n(1st :$d2012 :$cSaint Gall, Switzerland)
830 0 $aRecent results in cancer research ;$v196.
988 $a20121217
906 $0OCLC